| NCT ID | NCT06770751 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul University - Cerrahpasa |
| Condition | Intensive Care Patients |
| Study Type | OBSERVATIONAL |
| Enrollment | 122 participants |
| Start Date | 2025-01-13 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 122 participants in total. It began in 2025-01-13 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this prospective cohort study was to investigate the effect of the time spent with relatives of patients treated in a tertiary intensive care unit on patient outcomes. The main question it aimed to answer was: Does spending more time with relatives of patients in intensive care result in lower sedative agent requirements? Does spending more time with relatives of patients in intensive care result in less delirium, fewer ventilator days, and shorter ICU stays?
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 and over. * Patients with at least one family member actively involved in the care process in the ICU. Exclusion Criteria: * Patients with pre-existing cognitive impairment or dementia. * Patients with severe traumatic brain injury. * Patients with an expected mortality in the ICU of more than 80%. * Absence of family members for patients admitted to the ICU.
Contact & Investigator
Oktay Demirkiran, Professor
STUDY DIRECTOR
İstanbul University - Cerrahpaşa, Cerrahpaşa Medical Faculty
Frequently Asked Questions
Who can join the NCT06770751 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intensive Care Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06770751 currently recruiting?
Yes, NCT06770751 is actively recruiting participants. Contact the research team at oguzhan.kayhan@iuc.edu.tr for enrollment information.
Where is the NCT06770751 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06770751 clinical trial?
NCT06770751 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Oktay Demirkiran, Professor at İstanbul University - Cerrahpaşa, Cerrahpaşa Medical Faculty. The trial plans to enroll 122 participants.